The Food and Drug Administration says it has approved a Johnson & Johnson tuberculosis drug called Sirturo.
It's for use with other older drugs to fight hard-to-treat tuberculosis, which mainly involves the lungs.
Roughly one-third of the world's population is estimated to be infected with the bacteria causing tuberculosis, which can be deadly.
